Endologix, maker of minimally invasive devices to treat vascular diseases, has rebranded as Rhevera Medical. In a news release posted yesterday, the Santa Rosa, California–based company said the name combines "rheo," Greek for flow, and "vera," Latin for true. According to the company, the name expresses its tech focus on providing true, … [Read more...] about Endologix is now Rhevera Medical
Business
HighLife raises more than $90M to advance its TMVR system
HighLife (Paris) recently announced it raised €80 million (more than $90 million U.S.) for a U.S. pivotal study and expanded European commercialization of its TMVR system. The successfully completed fundraise, announced Sept. 22, was co-led by Andera Partners, Sofinnova Partners, Supernova Invest and Mérieux Equity Partners. Other new investors … [Read more...] about HighLife raises more than $90M to advance its TMVR system
Anaconda Biomed brings in $56 million
Anaconda Biomed recently announced a $56 million funding round to advance what it describes as next-generation, novel thrombectomy catheters. The Barcelona-based company said the funds will support completion of the ongoing Athena pivotal IDE study, a prospective, randomized, 327-subject trial intended to evaluate the safety and performance of … [Read more...] about Anaconda Biomed brings in $56 million
Abbott earns FDA approval for new dual-energy ablation catheter
Abbott (NYSE: ABT) earned FDA approval for its new dual-energy catheter, TactiFlex Duo sensor-enabled ablation catheter. TactiFlex Duo joins Johnson & Johnson MedTech’s ThermoCool SmartTouch SF and Medtronic's Affera Sphere-9 catheter in the U.S. dual-energy ablation catheter market. Medtronic won its Sphere-9 approval in 2024, and J&J … [Read more...] about Abbott earns FDA approval for new dual-energy ablation catheter
Corcym achieves first-in-human implant of TriMemo for tricuspid valve repair
Corcym today announced that Cleveland Clinic doctors performed the first-in-human implantation of TriMemo, a semi-rigid ring designed to repair the tricuspid valve. The ring comprises three layers: a carbon film coating over the oval silicone sheath, which together guard the laser-cut nitinol cell structure. Nitinol, a superelastic … [Read more...] about Corcym achieves first-in-human implant of TriMemo for tricuspid valve repair
Jupiter Endovascular appoints Catalin Toma as chief medical officer
Jupiter Endovascular, an endovascular interventions developer, has appointed interventional cardiologist Dr. Catalin Toma as chief medical officer, a new role for the company. Toma brings clinical and research experience across the structural heart and interventional landscape to his new role with Jupiter Endovascular, the company said … [Read more...] about Jupiter Endovascular appoints Catalin Toma as chief medical officer
Xeltis raises $23.3M to bring vascular access device to US
Xeltis announced today that it raised $23.3 million (€20.5m) in funding from both new and existing shareholders. Eindhoven, the Netherlands-based company said that, combined with $55 million raised at the end of 2025, the latest funding demonstrates investor confidence in its strategy and strengthens its ability to execute on clinical, … [Read more...] about Xeltis raises $23.3M to bring vascular access device to US
RapidPulse raises $48M for thrombectomy tech as Medtronic invests
RapidPulse announced today that it closed a $48 million Series B financing, with Medtronic among the investors participating. Miami-based RapidPulse develops next-generation aspiration technology for treating acute ischemic stroke. Its latest funding adds to $10.5 million raised in 2022. Medtronic co-led the funding round alongside TechWald … [Read more...] about RapidPulse raises $48M for thrombectomy tech as Medtronic invests
Xeltis has first commercial implant of vascular access device for hemodialysis
Xeltis announced today that it began European commercialization efforts for its aXess vascular access device. Dr. Dominik Liebetrau at Artemed Klinikum Munich South, Germany, completed the first successful commercial treatment with aXess. aXess, the company’s restorative vascular access conduit, is designed to enable the creation of a new, … [Read more...] about Xeltis has first commercial implant of vascular access device for hemodialysis
Johnson & Johnson launches ThermoCool SmartTouch ablation tech in Europe
Johnson & Johnson (NYSE:JNJ) announced today that it launched its dual-energy ThermoCool SmartTouch platform in Europe. The launch expands access in the region to dual-energy catheter ablation for personalized care across workflows, anatomies and procedural strategies. J&J's ThermoCool SmartTouch platform combines the ThermoCool … [Read more...] about Johnson & Johnson launches ThermoCool SmartTouch ablation tech in Europe
